Skip to main content
SpringerLink
Log in

Depression care for US prostate cancer patients: more QALYs, lower cost

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Erim DO. Cost-Effectiveness of the Providing Depression Care for People With Cancer Program to Patients With Prostate Cancer in the United States. Value in Health : 31 Oct 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.09.008

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Depression care for US prostate cancer patients: more QALYs, lower cost. PharmacoEcon Outcomes News 866, 11 (2020). https://doi.org/10.1007/s40274-020-7271-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7271-x

Search

Navigation